Melanotransferrin/CD228/MFI2 Antibody (SC-005) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28837PE
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # SC-005
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Melanotransferrin/CD228/MFI2 Antibody (SC-005) [PE]
Immunogen
Melanotransferrin / CD228
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Applications for Melanotransferrin/CD228/MFI2 Antibody (SC-005) [PE]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Melanotransferrin/CD228
Alternate Names
CD228, MAP97, MFI2, MTF, p97
Gene Symbol
MELTF
Additional Melanotransferrin/CD228 Products
Product Documents for Melanotransferrin/CD228/MFI2 Antibody (SC-005) [PE]
Product Specific Notices for Melanotransferrin/CD228/MFI2 Antibody (SC-005) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...